Related Experiment Videos
[Renal crisis in systemic sclerosis].
G Haugeberg1, R Bie, R Orstavik
1Revmatologisk avdeling, Vest-Agder Sentralsykehus, Kristiansand.
Summary
Systemic sclerosis can cause acute kidney injury, known as renal crisis, with high mortality. Early ACE-inhibitor treatment significantly improves outcomes for patients with this rare connective tissue disease.
Area of Science:
- Nephrology
- Rheumatology
- Internal Medicine
Background:
- Systemic sclerosis is a rare connective tissue disease impacting multiple organs.
- Renal involvement, including chronic and acute nephritis, occurs in a significant percentage of patients.
- Acute nephritis in systemic sclerosis is termed renal crisis, carrying high morbidity and mortality.
Observation:
- Renal crisis is a severe complication of systemic sclerosis.
- Autopsy studies reveal interstitial renal changes in up to 80% of systemic sclerosis cases.
- Patients with diffuse systemic sclerosis and anti-RNA-polymerase antibodies are at higher risk.
Findings:
- Treatment with angiotensin-converting enzyme (ACE) inhibitors has markedly improved the prognosis of renal crisis.
- Early detection and intervention are crucial for managing renal complications in systemic sclerosis.
Implications:
- ACE inhibitors represent a breakthrough in managing systemic sclerosis-associated renal crisis.
- Vigilant monitoring and prompt treatment are essential for improving patient outcomes in systemic sclerosis.
- Further research into risk stratification and early detection markers is warranted.